PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
9.45%
Revenue growth at 50-75% of 2127.T's 17.00%. Martin Whitman would worry about competitiveness or product relevance.
8.06%
Gross profit growth at 50-75% of 2127.T's 11.83%. Martin Whitman would question if cost structure or brand is lagging.
14.43%
EBIT growth below 50% of 2127.T's 44.09%. Michael Burry would suspect deeper competitive or cost structure issues.
17.38%
Operating income growth at 50-75% of 2127.T's 34.22%. Martin Whitman would doubt the firm’s ability to compete efficiently.
50.76%
Net income growth 1.25-1.5x 2127.T's 35.25%. Bruce Berkowitz would see if strategic cost cutting or product mix explains this difference.
50.77%
EPS growth 1.25-1.5x 2127.T's 35.18%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
50.77%
Diluted EPS growth 1.25-1.5x 2127.T's 35.62%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
35.29%
Dividend growth of 35.29% while 2127.T is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
6.12%
OCF growth of 6.12% while 2127.T is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
6.12%
FCF growth of 6.12% while 2127.T is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
25.67%
10Y revenue/share CAGR under 50% of 2127.T's 504.10%. Michael Burry would suspect a lasting competitive disadvantage.
50.38%
5Y revenue/share CAGR under 50% of 2127.T's 138.43%. Michael Burry would suspect a significant competitive gap or product weakness.
15.60%
3Y revenue/share CAGR under 50% of 2127.T's 92.61%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
64.86%
Below 50% of 2127.T's 550.56%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
30.47%
Below 50% of 2127.T's 227.93%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
4.42%
Below 50% of 2127.T's 120.79%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
134.80%
Below 50% of 2127.T's 529.21%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
93.84%
5Y equity/share CAGR at 50-75% of 2127.T's 140.01%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
44.89%
3Y equity/share CAGR similar to 2127.T's 49.47%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
283.33%
Below 50% of 2127.T's 860.00%. Michael Burry might see weaker long-term distribution growth, raising questions about the firm's capital allocation.
155.56%
Dividend/share CAGR of 155.56% while 2127.T is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
91.67%
3Y dividend/share CAGR above 1.5x 2127.T's 60.00%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
32.94%
AR growth is negative/stable vs. 2127.T's 127.18%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
10.47%
Inventory shrinking or stable vs. 2127.T's 23.78%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
11.68%
Asset growth 1.25-1.5x 2127.T's 8.63%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
3.71%
50-75% of 2127.T's 5.18%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
187.81%
Debt growth of 187.81% while 2127.T is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
-39.78%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.